Osimertinib for maintenance treatment of EGFR mutation-positive locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation [ID6223]
In development
Reference number: GID-TA11232
Expected publication date:
Following the committee meeting on 20 November 2025 further work is being conducted and the expected publication date has been amended.